MAIA Biotechnology Statistics
Total Valuation
MAIA has a market cap or net worth of $78.87 million. The enterprise value is $45.07 million.
Important Dates
The last earnings date was Monday, May 11, 2026, before market open.
| Earnings Date | May 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MAIA has 60.67 million shares outstanding. The number of shares has increased by 47.62% in one year.
| Current Share Class | 60.67M |
| Shares Outstanding | 60.67M |
| Shares Change (YoY) | +47.62% |
| Shares Change (QoQ) | +21.56% |
| Owned by Insiders (%) | 8.27% |
| Owned by Institutions (%) | 4.17% |
| Float | 55.62M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 8.32 |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.86 |
| P/TBV Ratio | 2.86 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.59
| Current Ratio | 5.59 |
| Quick Ratio | 5.44 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -148.29% and return on invested capital (ROIC) is -98.59%.
| Return on Equity (ROE) | -148.29% |
| Return on Assets (ROA) | -68.33% |
| Return on Invested Capital (ROIC) | -98.59% |
| Return on Capital Employed (ROCE) | -88.94% |
| Weighted Average Cost of Capital (WACC) | 5.49% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.87M |
| Employee Count | 13 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -32.29% in the last 52 weeks. The beta is 0.23, so MAIA's price volatility has been lower than the market average.
| Beta (5Y) | 0.23 |
| 52-Week Price Change | -32.29% |
| 50-Day Moving Average | 1.38 |
| 200-Day Moving Average | 1.53 |
| Relative Strength Index (RSI) | 44.61 |
| Average Volume (20 Days) | 580,956 |
Short Selling Information
The latest short interest is 2.83 million, so 4.67% of the outstanding shares have been sold short.
| Short Interest | 2.83M |
| Short Previous Month | 1.82M |
| Short % of Shares Out | 4.67% |
| Short % of Float | 5.10% |
| Short Ratio (days to cover) | 3.76 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -25.79M |
| Pretax Income | -24.25M |
| Net Income | -24.25M |
| EBITDA | n/a |
| EBIT | -25.79M |
| Earnings Per Share (EPS) | -$0.67 |
Full Income StatementBalance Sheet
The company has $34.41 million in cash and n/a in debt, with a net cash position of $34.41 million or $0.57 per share.
| Cash & Cash Equivalents | 34.41M |
| Total Debt | n/a |
| Net Cash | 34.41M |
| Net Cash Per Share | $0.57 |
| Equity (Book Value) | 27.76M |
| Book Value Per Share | 0.46 |
| Working Capital | 28.99M |
Full Balance SheetCash Flow
| Operating Cash Flow | -19.95M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
